Association of Biotechnology Led Enterprises

News

BIRAC invites proposals under R&D for Guar-Gum before 31st August 2019

The Primary scope of the program is to support R & D gaps of guar and its derivatives for the long-term profitability and sustainability of guar industry in India.

Jul 17, 2019

By : Team ABLE

ICMR initiates clinical trial of TB vaccine for adults

The ultimate goal is to develop a vaccine that can prevent active TB and be a part of large campaigns aimed at eliminating the disease.

Jul 16, 2019

By : Team ABLE

Boehringer Ingelheim acquires AMAL Therapeutics to enrich cancer immunology portfolio

Boehringer Ingelheim plans to develop new therapies by combining assets from its cancer immunology portfolio with AMAL’s proprietary KISIMA immunization platform.

Jul 16, 2019

By : Team ABLE

WHO-UNICEF: 20 million children miss out on lifesaving measles, diphtheria and tetanus vaccines in 2018

20 million children worldwide – more than 1 in 10 – missed out on lifesaving vaccines such as measles, diphtheria and tetanus in 2018, according to new data from WHO and UNICEF.

Jul 16, 2019

By : Team ABLE